Collagen-derived dipeptide prolyl-hydroxyproline promotes differentiation of MC3T3-E1 osteoblastic cells

Biochemical and Biophysical Research Communications

Volumn 453, Issue 3, 2014, Pages 498-501

  Kimira, Yoshifumi ^a   Ogura, Kana ^a   Taniuchi, Yuri ^a   Kataoka, Aya ^b   Inoue, Naoki ^b   Sugihara, Fumihito ^b   Nakatani, Sachie ^a   Shimizu, Jun ^a   Wada, Masahiro ^a   Mano, Hiroshi ^a  

^a JOSAI UNIVERSITY   (Japan)

^b Nitta Gelatin Inc   (Japan)

Author keywords

Collagen derived peptide; Osteoblast differentiation; Prolyl hydroxyproline

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN; COLLAGEN DERIVED DIPEPTIDE PROLYL HYDROXYPROLINE; DIPEPTIDE DERIVATIVE; HYDROXYPROLINE; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; DIPEPTIDE; OSTERIX PROTEIN, MOUSE; PROLYL-4-HYDROXYPROLINE; RUNX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; UPREGULATION; 3T3 CELL LINE; ANIMAL; BONE MINERALIZATION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DIPEPTIDES; MICE; OSTEOBLASTS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84918593699     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.121     Document Type: Article

References (22)

1. A. Erlebacher, E.H. Filvaroff, S.E. Gitelman, et al., Toward a molecular understanding of skeletal development, Cell 80 (1995) 371-378.
2. N. Ortega, D.J. Behonick, Z. Werb, Matrix remodeling during endochondral ossification, Trends Cell Biol. 2 (2004) 86-93.
3. S. Ichikawa, M. Morifuji, H. Ohara, et al., Hydroxyproline-containing dipeptides and tripeptides quantified at high concentration in human blood after oral administration of gelatin hydrolysate, Int. J. Food Sci. Nutr. 61 (2010) 52-60.
4. F. Sugihara, N. Inoue, M. Kuwamori, et al., Quantification of hydroxyprolylglycine (Hyp-Gly) in human blood after ingestion of collagen hydrolysate, J. Biosci. Bioeng. 113 (2012) 202-203.
5. K. Iwai, T. Hasegawa, Y. Taguchi, et al., Identification of food-derived peptides in human blood after oral ingestion of gelatin hydrolysates, J. Agric. Food Chem. 53 (2005) 6531-6536.
6. M. Aito-Inoue, K. Ohtsuki, Y. Nakamura, et al., Improvement in isolation and identification of food-derived peptides in human plasma based on precolumn derivatization of peptides with phenyl isothiocyanate, J. Agric. Food Chem. 54 (2006) 5261-5266.
7. H. Ohara, H. Matsumoto, K. Ito, et al., Comparison of quantity and structures of hydroxyproline-containing peptides in human blood after oral ingestion of gelatin hydrolysates from different sources, J. Agric. Food Chem. 55 (2007) 1532-1535.
8. C. Liu, K. Sugita, K. Nihei, et al., Absorption of hydroxyproline containing peptides in vascularly perfused rat small intestine in situ, Biosci. Biotechnol. Biochem. 73 (2009) 1741-1747.
9. Y. Shigemura, K. Iwai, F. Morimatsu, et al., Effect of prolyl-hydroxyproline (Pro-Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin, J. Agric. Food Chem. 55 (2007) 1532-1535.
10. S. Nakatani, H. Mano, C. Sampei, et al., Chondroprotective effect of the bioactive peptide prolyl-hydroxyproline in mouse articular cartilage in vitro and in vivo, Osteoarthritis Cartilage 17 (2009) 1620-1627.
11. J. Wu, M. Fujioka, K. Sugimoto, et al., Assessment of effectiveness of oral administration of collagen peptide on bone metabolism in growing and mature rats, J. Bone Miner. Metab. 22 (2004) 547-553.
12. S. Yamada, H. Nagaoka, M. Terajim, et al., Effects of fish collagen peptides on collagen post-translational modifications and mineralization in an osteoblastic cell culture system, Dent. Mater. J. 32 (2013) 88-95.
13. J. Liu, B. Zhang, S. Song, et al., Bovine collagen peptides compounds promote the proliferation and differentiation of MC3T3-E1 pre-osteoblasts, PLoS One 9 (2014) e99920.
14. H.K. Kim, M.G. Kim, K.H. Leem, Osteogenic activity of collagen peptide via ERK/ MAPK pathway mediated boosting of collagen synthesis and its therapeutic efficacy in osteoporotic bone by back-scattered electron imaging and microarchitecture analysis, Molecules 18 (2013) 15474-15489.
15. H. Mano, S. Nakatani, R. Aoyagi, et al., IF3, a novel cell-differentiation factor, highly expressed in murine liver and ovary, Biochem. Biophys. Res. Commun. 297 (2002) 323-328.
16. C. Zhang, J. Peng, S. Wu, et al., Dioscin promotes osteoblastic proliferation and differentiation via Lrp5 and ER pathway in mouse and human osteoblast-like cell lines, J. Biomed. Sci. 21:30 (2014).
17. J.N. Beresford, S.E. Graves, C.A. Smoothy, Formation of mineralized nodules by bone derived cells in vitro: a model of bone formation?, Am J. Med. Genet. 45 (1993) 163-178.
18. G.S. Stein, J.B. Lian, T.A. Owen, Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation, FASEB J. 4 (1990) 3111-3123.
19. M. Weinreb, D. Shinar, G.A. Rodan, Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization, J. Bone Miner. Res. 5 (1990) 831-842.
20. M.J. Don, L.C. Lin, W.F. Chiou, Neobavaisoflavone stimulates osteogenesis via p38-mediated up-regulation of transcription factors and osteoid genes expression in MC3T3-E1 cells, Phytomedicine 19 (2012) 551-561.
21. T. Komori, Regulation of bone development and extracellular matrix protein genes by RUNX2, Cell Tissue Res. 339 (2010) 189-195.
22. E. Ogawa, M. Inuzuka, M. Maruyama, et al., Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha, Virology 194 (1993) 314-331.